ArticleInternational journal of molecular sciences2023

HBV Enhances Sorafenib Resistance in Hepatocellular Carcinoma by Reducing Ferroptosis via SRSF2-Mediated Abnormal PCLAF Splicing.

Lijuan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.